about
Drug discovery in ophthalmology: past success, present challenges, and future opportunitiesExtended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection.A Drug Delivery System for Administration of Anti-TNF-α Antibody.Microrobots: a new era in ocular drug delivery.Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.Clinicians' perspectives on the use of drug-eluting contact lenses for the treatment of glaucoma.Molecularly imprinted polymeric micro- and nano-particles for the targeted delivery of active molecules.A review on therapeutic contact lenses for ocular drug delivery.Development of ciprofloxacin-loaded contact lenses using fluorous chemistry.In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems.Retrospective evaluation of corneal reconstruction using ACell Vet(™) alone in dogs and cats: 82 cases.Zero-Order Antibiotic Release from Multilayer Contact Lenses: Nonuniform Drug and Diffusivity Distributions Produce Constant-Rate Drug Delivery.Interaction with therapeutic soft contact lenses affects the intraocular efficacy of tropicamide and latanoprost in dogs.Release of betaine and dexpanthenol from vitamin E modified silicone-hydrogel contact lenses.New platforms for multi-functional ocular lenses: engineering double-sided functionalized nano-coatings.Polymeric Materials in Ocular Drug Delivery Systems
P2860
Q26771638-B3E33A51-DA3A-4351-AB88-8A1784169098Q34509564-16591D66-97FC-4B8E-807E-9561CA4C96DCQ36683809-1C832800-8152-4206-9510-15D37F5E690DQ38227020-941C1A28-9DBF-446B-8987-E519B80C61FBQ38239017-DC6E1610-E708-4604-A072-9B3C90347420Q38270686-FD745CFF-37EA-4DA3-9AFE-B9F7DD2E64D7Q38357073-1FB2926C-FD16-4204-B4A5-445E2A4F0384Q38715163-AA644750-C017-4B0B-8BFE-A7422A0848E2Q40336319-8161EE73-19F8-4D0A-8C75-657AB1310F20Q42773028-0EEF4DE5-70F2-4F9F-9909-88D7D5F75F05Q42943888-EC92947A-2D13-4E5C-9E8F-037DE52FE1A2Q44858143-BFC3B73A-BD68-4611-BFA7-053437BEC71CQ50904783-FF9D3E45-C823-4CB9-8843-A77B959CF766Q51705346-B22AAE39-58EF-490B-9E7D-85D37A350219Q53550463-459FC3E7-5ED5-435F-BE7F-BD84C807372DQ53645918-F7519858-9AC5-413A-831F-4B64458FC1D8Q58436049-7AB6BA2E-AB04-42F0-9D1F-53F4D172CD12
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Contact lenses as a platform for ocular drug delivery.
@en
type
label
Contact lenses as a platform for ocular drug delivery.
@en
prefLabel
Contact lenses as a platform for ocular drug delivery.
@en
P2093
P2860
P1476
Contact lenses as a platform for ocular drug delivery.
@en
P2093
Anuj Chauhan
Kuan-Hui Hsu
Lokendrakumar C Bengani
Samuel Gause
P2860
P304
P356
10.1517/17425247.2013.821462
P407
P577
2013-07-22T00:00:00Z